World Journal of Gastrointestinal Oncology

Papers
(The TQCC of World Journal of Gastrointestinal Oncology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-09-01 to 2024-09-01.)
ArticleCitations
Young-onset colorectal cancer: A review47
Early-onset colorectal cancer: Current insights and future directions36
Liquid biopsy in cholangiocarcinoma: Current status and future perspectives34
Colorectal cancer screening in the COVID-19 era31
Neoadjuvant chemotherapy for colorectal liver metastases: A contemporary review of the literature27
Propofol induces ferroptosis and inhibits malignant phenotypes of gastric cancer cells by regulating miR-125b-5p/STAT3 axis26
Synergistic anti-liver cancer effects of curcumin and total ginsenosides25
Nanotechnology and pancreatic cancer management: State of the art and further perspectives24
Colorectal cancer carcinogenesis: From bench to bedside22
Radiomics in hepatocellular carcinoma: A state-of-the-art review21
Diverse roles of FOXO family members in gastric cancer21
Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences21
Small bowel adenocarcinoma: An overview21
Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report20
Diagnostic value of four serum exosome microRNAs panel for the detection of colorectal cancer20
Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis20
Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives20
Helicobacter pylori, gastric microbiota and gastric cancer relationship: Unrolling the tangle20
Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures19
BRAFV600E mutant colorectal cancer cells mediate local immunosuppressive microenvironment through exosomal long noncoding RNAs19
Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma19
Regulatory RNAs, microRNA, long-non coding RNA and circular RNA roles in colorectal cancer stem cells19
Endoscopic or percutaneous biliary drainage in hilar cholangiocarcinoma: When and how?18
Overgrowth of Lactobacillus in gastric cancer18
Prognostic significance of KIF23 expression in gastric cancer18
Recent advances in targeted therapy for pancreatic adenocarcinoma17
Gastric epithelial histology and precancerous conditions17
Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside17
Nutritional therapy for hepatocellular carcinoma17
Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway17
Development of artificial intelligence technology in diagnosis, treatment, and prognosis of colorectal cancer17
Gallbladder cancer: Historical treatment and new management options17
Colorectal cancer in Arab world: A systematic review17
Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis16
Digestive cancer incidence and mortality among young adults worldwide in 2020: A population-based study15
Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review15
Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons14
Review of incidence and outcomes of treatment of cholangiocarcinoma in patients with primary sclerosing cholangitis14
Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management14
Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma14
Myeloid-derived suppressor cells in gastrointestinal cancers: A systemic review14
Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases14
Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease13
Decreased expression of the long non-coding RNA HOXD-AS2 promotes gastric cancer progression by targeting HOXD8 and activating PI3K/Akt signaling pathway13
Highly accurate colorectal cancer prediction model based on Raman spectroscopy using patient serum13
Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours13
Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review13
Current role of hepatopancreatoduodenectomy for the management of gallbladder cancer and extrahepatic cholangiocarcinoma: A systematic review13
Biomarkers for hepatocellular carcinoma based on body fluids and feces13
Management of obstructive colon cancer: Current status, obstacles, and future directions12
Neoantigen vaccine: An emerging immunotherapy for hepatocellular carcinoma12
Diagnostic performance of narrow-band imaging international colorectal endoscopic and Japanese narrow-band imaging expert team classification systems for colorectal cancer and precancerous lesions12
Advances in postoperative adjuvant therapy for primary liver cancer12
Poorly cohesive cells gastric carcinoma including signet-ring cell cancer: Updated review of definition, classification and therapeutic management12
Management of single pulmonary metastases from colorectal cancer: State of the art12
Multimodal treatment in oligometastatic gastric cancer12
Application of the woodchuck animal model for the treatment of hepatitis B virus-induced liver cancer12
Notch signalling pathway in development of cholangiocarcinoma12
Recent update on comprehensive therapy for advanced hepatocellular carcinoma12
Gastric cancer: An epigenetic view12
Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review11
Total neoadjuvant therapy vs standard therapy of locally advanced rectal cancer with high-risk factors for failure11
Bromodomain and extra-terminal inhibitors emerge as potential therapeutic avenues for gastrointestinal cancers11
Role of exosomal long non-coding RNAs in colorectal cancer11
Lateral pelvic lymph nodes for rectal cancer: A review of diagnosis and management11
Molecular regulatory mechanism of ferroptosis and its role in gastrointestinal oncology: Progress and updates11
Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses11
LncRNA C9orf139 can regulate the growth of pancreatic cancer by mediating the miR-663a/Sox12 axis11
Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression11
Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics11
Non-surgical treatment of hilar cholangiocarcinoma11
Neutrophile-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios as prognostic and response biomarkers for resectable locally advanced gastric cancer11
Mesenchymal stem cell-derived exosomes for gastrointestinal cancer11
Molecular determinants of response to 5-fluorouracil-based chemotherapy in colorectal cancer: The undisputable role of micro-ribonucleic acids11
Prognostic impact of at least 12 lymph nodes after neoadjuvant therapy in rectal cancer: A meta-analysis11
Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways11
Hydrogen-rich water exerts anti-tumor effects comparable to 5-fluorouracil in a colorectal cancer xenograft model10
Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy10
Outcomes of curative esophageal cancer surgery in elderly: A meta-analysis10
Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis10
Extracellular vesicles: General features and usefulness in diagnosis and therapeutic management of colorectal cancer10
Prognostic significance of Borrmann type combined with vessel invasion status in advanced gastric cancer10
Immune evasion mechanisms and therapeutic strategies in gastric cancer10
Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions10
Primary malignant vascular tumors of the liver in children: Angiosarcoma and epithelioid hemangioendothelioma10
Association between intestinal neoplasms and celiac disease: A review10
Influence of primary tumor location and resection on survival in metastatic colorectal cancer10
Molecular testing for colorectal cancer: Clinical applications10
Exosomes as potential diagnosis and treatment for liver cancer10
Novel perspective in pancreatic cancer therapy: Targeting ferroptosis pathway10
Endoscopic ultrasound assessment and tissue acquisition of mediastinal and abdominal lymph nodes9
Is the combination of immunotherapy with conventional chemotherapy the key to increase the efficacy of colorectal cancer treatment?9
Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy9
Sporadic fundic gland polyps with dysplasia or carcinoma: Clinical and endoscopic characteristics9
Fibrolamellar hepatocellular carcinoma: A rare but unpleasant event9
Update on the management of the gastrointestinal effects of radiation9
Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy9
Effects ofHelicobacter pyloriinfection in gastrointestinal tract malignant diseases: From the oral cavity to rectum9
Glutamine deprivation impairs function of infiltrating CD8+ T cells in hepatocellular carcinoma by inducing mitochondrial damage and apoptosis9
Characterization of metabolic landscape in hepatocellular carcinoma9
Current controversies and advances in the management of pancreatic adenocarcinoma9
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis9
VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors9
Cryptotanshinone inhibits cytotoxin-associated gene A-associated development of gastric cancer and mucosal erosions8
Engineering nanotheranostic strategies for liver cancer8
Endoscopic ultrasound-guided ablation of solid pancreatic lesions: A systematic review of early outcomes with pooled analysis8
Prognostic value of claudin 18.2 expression in gastric adenocarcinoma8
Macrophages play a role in inflammatory transformation of colorectal cancer8
Familial adenomatous polyposis and changes in the gut microbiota: New insights into colorectal cancer carcinogenesis8
Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities8
Traditional Chinese medicine for transformation of gastric precancerous lesions to gastric cancer: A critical review8
Plexiform fibromyxoma: Review of rare mesenchymal gastric neoplasm and its differential diagnosis8
Relation between skeletal muscle volume and prognosis in rectal cancer patients undergoing neoadjuvant therapy8
Liquid biopsy approach to pancreatic cancer8
Intratumour microbiome of pancreatic cancer8
Current status of non-surgical treatment of locally advanced pancreatic cancer8
Methylation changes at the GNAS imprinted locus in pancreatic cystic neoplasms are important for the diagnosis of malignant cysts8
Hypoxia and its impact on the tumour microenvironment of gastroesophageal cancers8
MicroRNA expression in inflammatory bowel disease-associated colorectal cancer8
Blood exosomal micro ribonucleic acid profiling reveals the complexity of hepatocellular carcinoma and identifies potential biomarkers for differential diagnosis8
Outcomes of neoadjuvant chemoradiotherapy followed by radical resection for T4 colorectal cancer8
What is the best surgical procedure of transverse colon cancer? An evidence map and minireview8
Endoscopic radiofrequency ablation for malignant biliary obstruction8
How the COVID-19 pandemic has affected the colorectal cancer screening in Italy: A minireview7
Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma7
Can dietary flavonoids be useful in the personalized treatment of colorectal cancer?7
Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer7
Role of neoadjuvant therapy for nonmetastatic pancreatic cancer: Current evidence and future perspectives7
Comparison of prognostic factors in different age groups and prognostic significance of neutrophil-lymphocyte ratio in patients with gastric cancer7
Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma7
Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy7
Solid extraintestinal malignancies in patients with inflammatory bowel disease7
Vasoactive intestinal peptide secreting tumour: An overview7
Challenges and exploration for immunotherapies targeting cold colorectal cancer7
Sarcopenia in pancreatic cancer: Effect on patient outcomes7
Scoping out the future: The application of artificial intelligence to gastrointestinal endoscopy7
Robotic resection of liver focal nodal hyperplasia guided by indocyanine green fluorescence imaging: A preliminary analysis of 23 cases7
Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study7
Practical considerations for colorectal cancer screening in older adults7
Research progress of integrated traditional Chinese and Western medicine in the treatment of advanced gastric cancer7
Laparoscopic liver resection for colorectal liver metastases — short- and long-term outcomes: A systematic review7
Pancreatic head vs pancreatic body/tail cancer: Are they different?7
Sex as an effect modifier in the association between alcohol intake and gastric cancer risk7
Proteasome regulators in pancreatic cancer6
Proliferating cell nuclear antigen clamp associated factor, a potential proto-oncogene with increased expression in malignant gastrointestinal tumors6
Emerging role of caldesmon in cancer: A potential biomarker for colorectal cancer and other cancers6
Comprehensive molecular characterization and identification of prognostic signature in stomach adenocarcinoma on the basis of energy-metabolism-related genes6
Molecular-targeted therapy toward precision medicine for gastrointestinal caner: Current progress and challenges6
Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review6
Comparison of survival between adolescent and young adult vs older patients with hepatocellular carcinoma6
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching6
Should we resect colorectal cancer in patients over the age of 85?6
Screening strategy for gastrointestinal and hepatopancreatobiliary cancers in cystic fibrosis6
Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine6
Berberine retarded the growth of gastric cancer xenograft tumors by targeting hepatocyte nuclear factor 4α6
Predictors for malignant potential and deep submucosal invasion in colorectal laterally spreading tumors6
Latest therapeutic target for gastric cancer: Anthrax toxin receptor 16
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives6
Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China6
Clinical implications of interleukins-31, 32, and 33 in gastric cancer6
High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation6
Radiofrequency ablation in the management of primary hepatic and biliary tumors6
Portal vein embolization failure: Current strategies and future perspectives to improve liver hypertrophy before major oncological liver resection6
Angiotensin-converting enzyme 2 connects COVID-19 with cancer and cancer immunotherapy6
Molecular methods for colorectal cancer screening: Progress with next-generation sequencing evolution6
Serum vascular endothelial growth factor as a tumor marker for hepatocellular carcinoma in hepatitis C virus-related cirrhotic patients6
Clinical management for malignant afferent loop obstruction6
Preventive and inhibitive effects of Yiwei Xiaoyu granules on the development and progression of spasmolytic polypeptide-expressing metaplasia lesions6
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows6
Same day yttrium-90 radioembolization with single photon emission computed tomography/computed tomography: An opportunity to improve care during the COVID-19 pandemic and beyond6
Stereotactic radiotherapy for intrahepatic cholangiocarcinoma6
Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis6
Effects of dietary zinc deficiency on esophageal squamous cell proliferation and the mechanisms involved6
Angiogenesis in gastrointestinal stromal tumors: From bench to bedside6
Role of mammalian target of rapamycin complex 2 in primary and secondary liver cancer6
Effect of oncometabolic surgery on gastric cancer: The remission of hypertension, type 2 diabetes mellitus, and beyond6
Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study6
Clinical efficacy and prognostic risk factors of endoscopic radiofrequency ablation for gastric low-grade intraepithelial neoplasia6
Clinicopathological differences, risk factors and prognostic scores for western patients with intestinal and diffuse-type gastric cancer6
Cutaneous metastases of pancreatic carcinoma to the labia majora: A case report and review of literature5
RNA-Seq profiling of circular RNAs in human colorectal cancer 5-fluorouracil resistance and potential biomarkers5
Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer5
Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment5
Rare common bile duct metastasis of breast cancer: A case report and literature review5
Regorafenib combined with programmed cell death-1 inhibitor against refractory colorectal cancer and the platelet-to-lymphocyte ratio’s prediction on effectiveness5
Interleukin-34 promotes the proliferation and epithelial-mesenchymal transition of gastric cancer cells5
Effect of obesity on post-operative outcomes following colorectal cancer surgery5
Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy5
Circular RNAs in hepatocellular carcinoma: Recent advances5
New frontiers in liver ultrasound: From mono to multi parametricity5
Application of metabolomics in clinical and laboratory gastrointestinal oncology5
Combined treatments in hepatocellular carcinoma: Time to put them in the guidelines?5
Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer5
Role of autophagy in gastric carcinogenesis5
Role of ferroptosis in colorectal cancer5
Yield of surgery in solid pseudopapillary neoplasms of the pancreas: A case series and literature review5
Current guidelines in the surgical management of hereditary colorectal cancers5
Esophageal cancer screening, early detection and treatment: Current insights and future directions5
Computed tomography-based radiomic to predict resectability in locally advanced pancreatic cancer treated with chemotherapy and radiotherapy5
Minimally invasive vs open pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors5
Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma5
Role of endoscopic ultrasound in anticancer therapy: Current evidence and future perspectives5
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations5
Endoscopic papillectomy for ampullary adenomatous lesions: A literature review5
Oxidative imbalance increases the risk for colonic polyp and colorectal cancer development5
“Cold” colorectal cancer faces a bottleneck in immunotherapy5
Fecal microbial biomarkers combined with multi-target stool DNA test improve diagnostic accuracy for colorectal cancer5
Risk factors, prognostic predictors, and nomograms for pancreatic cancer patients with initially diagnosed synchronous liver metastasis5
Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis5
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma5
B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors5
Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis5
Moving forward in the treatment of cholangiocarcinoma4
O6-methylguanine DNA methyltransferase is upregulated in malignant transformation of gastric epithelial cells via its gene promoter DNA hypomethylation4
Deep learning-based radiomics based on contrast-enhanced ultrasound predicts early recurrence and survival outcome in hepatocellular carcinoma4
Influence of the heat irrigating effect of radiofrequency ablation on regional liver tissue in Bama miniature pigs4
Efficacy of neoadjuvant chemotherapy for initially resectable colorectal liver metastases: A retrospective cohort study4
Conservative management of malignant gastric outlet obstruction syndrome-evidence based evaluation of endoscopic ultrasound-guided gastroentero-anastomosis4
Prognostic value of modified Lauren classification in gastric cancer4
Role of tumor-associated macrophages in common digestive system malignant tumors4
Potential of six-transmembrane epithelial antigen of the prostate 4 as a prognostic marker for colorectal cancer4
Internal hemorrhoid harboring adenocarcinoma: A case report4
Statin as a therapeutic agent in gastroenterological cancer4
Survival outcomes and prognostic indicators for gastric cancer patients with positive peritoneal wash cytology but no peritoneal metastasis after radical gastrectomy4
Crohn’s disease with infliximab treatment complicated by rapidly progressing colorectal cancer: A case report4
Neoadjuvant chemotherapy without radiation as a potential alternative treatment for locally advanced rectal cancer: A meta-analysis4
Proteomic signatures of infiltrative gastric cancer by proteomic and bioinformatic analysis4
Does the addition of Braun anastomosis to Billroth II reconstruction on laparoscopic-assisted distal gastrectomy benefit patients?4
Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study4
Comprehensive analysis of distal-less homeobox family gene expression in colon cancer4
γ-glutamyl transferase-to-platelet ratio based nomogram predicting overall survival of gallbladder carcinoma4
Nutrition deprivation affects the cytotoxic effect of CD8 T cells in hepatocellular carcinoma4
Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway4
Overexpression of ELL-associated factor 2 suppresses invasion, migration, and angiogenesis in colorectal cancer4
Exosomes in metastasis of colorectal cancers: Friends or foes?4
EFNA1in gastrointestinal cancer: Expression, regulation and clinical significance4
Real-time fluorescence image-guided gastrointestinal oncologic surgery: Towards a new era4
Liver tumors in children with chronic liver diseases4
Prognostic impact of tumor deposits on overall survival in colorectal cancer: Based on Surveillance, Epidemiology, and End Results database4
MiR-30e-3p inhibits gastric cancer development by negatively regulating THO complex 2 and PI3K/AKT/mTOR signaling4
Diffuse reduction of spleen density is a novel prognostic marker for intrahepatic cholangiocarcinoma after curative resection4
KIFC3 promotes proliferation, migration and invasion of esophageal squamous cell carcinoma cells by activating EMT and β-catenin signaling4
Hemoglobin, albumin, lymphocyte, and platelet score as a predictor of prognosis in metastatic gastric cancer4
Digital single-operator cholangioscopy for biliary stricture after cadaveric liver transplantation4
Multinational survey on the preferred approach to management of Barrett’s esophagus in the Asia-Pacific region4
Biofeedback therapy combined with Baduanjin on quality of life and gastrointestinal hormone level in patients with colorectal cancer4
Diabetes mellitus contribution to the remodeling of the tumor microenvironment in gastric cancer4
Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy4
Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy4
Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers4
0.083411931991577